Dyne Therapeutics DYN
NASDAQ DYN
$16.54 +0.33 (+2.04%)
As of: Sep 30, 2026 · 10:25 AM EDT

Dyne Therapeutics (DYN) Other financing activities (2025 - 2026)

Updated

Dyne Therapeutics' Other financing activities was $30,000 in Q1 2026, up 233.3% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Other financing activities (2025 - 2026) Analysis & Trends

For FY2025, Other financing activities at Dyne Therapeutics came in at $558,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Dyne Therapeutics 2.71 Bn 2.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Dec 31, 2025 9,000.00
Sep 30, 2025 549,000.00
API Access

Dyne Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DYN&period=max&api_key=YOUR_API_KEY